Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees97
Employees97
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees97
Employees97
NBTX Key Statistics
Market cap1.74B
Market cap1.74B
Price-Earnings ratio-62.75
Price-Earnings ratio-62.75
Dividend yield—
Dividend yield—
Average volume40.98K
Average volume40.98K
High today$36.15
High today$36.15
Low today$31.68
Low today$31.68
Open price$35.47
Open price$35.47
Volume109.53K
Volume109.53K
52 Week high$57.14
52 Week high$57.14
52 Week low$4.18
52 Week low$4.18
NBTX News
TipRanks 4d
Nanobiotix Updates Share Capital and Voting Rights as of May 31, 2026Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Investing.com 6d
Leerink raises Nanobiotix stock price target on cancer drug data - Investing.com...
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.